Moiz A. Charania
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Moiz A. Charania has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Saravanan Ayyadurai
Department of Biology, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA, USA
10 shared publications - Didier Merlin
Department of Medicine, Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA, USA
9 shared publications - Hamed Laroui
Department of Medicine, Division of Digestive Diseases, Emory University, Atlanta, Georgia 30322, USA
9 shared publications Shanthi V. Sitaraman
Department of Medicine, Division of Digestive Diseases, Emory University, Atlanta, Georgia
9 shared publications- Yutao Yan
Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
9 shared publications Bo Xiao
5 shared publications
Latest Publications
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1792 PepT1 Expressed in Immune Cells Plays an Important Role in Induction of the Immune Response During Induced Colitis
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1792 PepT1 Expressed in Immune Cells Plays an Important Role in Induction of the Immune Response During Induced Colitis
- 1 March 2013
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 81 (3) , 923-934
Intestinal Epithelial CD98 Directly Modulates the Innate Host Response to Enteric Bacterial Pathogens
CD98 is a type II transmembrane glycoprotein whose expression increases in intestinal epithelial cells (IECs) during intestinal inflammation. Enteropathogenic Escherichia coli (EPEC) is a food-borne human pathogen that attaches to IECs and injects effector proteins directly into the host cells, thus provoking an inflammatory response. In the present study, we investigated CD98 and EPEC interactions in vitro and ex vivo and examined FVB wild-type (WT) and villin-CD98 transgenic mice overexpressing human CD98 in IECs (hCD98 Tg mice) and infected with Citrobacter rodentium as an in vivo model. In vivo studies indicated that CD98 overexpression, localized to the apical domain of colonic cells, increased the attachment of C. rodentium in mouse colons and resulted in increased expression of proinflammatory markers and decreased expression of anti-inflammatory markers. The proliferative markers Ki-67 and cyclin D1 were significantly increased in the colonic tissue of C. rodentium -infected hCD98 Tg mice compared to that of WT mice. Ex vivo studies correlate with the in vivo data. Small interfering RNA (siRNA) studies with Caco2-BBE cells showed a decrease in adherence of EPEC to Caco2 cells in which CD98 expression was knocked down. In vitro surface plasmon resonance (SPR) experiments showed direct binding between recombinant hCD98 and EPEC/ C. rodentium proteins. We also demonstrated that the partial extracellular loop of hCD98 was sufficient for direct binding to EPEC/ C. rodentium . These findings demonstrate the importance of the extracellular loop of CD98 in the innate host defense response to intestinal infection by attaching and effacing (A/E) pathogens.
- 1 March 2013
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 81 (3) , 923-934
Intestinal Epithelial CD98 Directly Modulates the Innate Host Response to Enteric Bacterial Pathogens
CD98 is a type II transmembrane glycoprotein whose expression increases in intestinal epithelial cells (IECs) during intestinal inflammation. Enteropathogenic Escherichia coli (EPEC) is a food-borne human pathogen that attaches to IECs and injects effector proteins directly into the host cells, thus provoking an inflammatory response. In the present study, we investigated CD98 and EPEC interactions in vitro and ex vivo and examined FVB wild-type (WT) and villin-CD98 transgenic mice overexpressing human CD98 in IECs (hCD98 Tg mice) and infected with Citrobacter rodentium as an in vivo model. In vivo studies indicated that CD98 overexpression, localized to the apical domain of colonic cells, increased the attachment of C. rodentium in mouse colons and resulted in increased expression of proinflammatory markers and decreased expression of anti-inflammatory markers. The proliferative markers Ki-67 and cyclin D1 were significantly increased in the colonic tissue of C. rodentium -infected hCD98 Tg mice compared to that of WT mice. Ex vivo studies correlate with the in vivo data. Small interfering RNA (siRNA) studies with Caco2-BBE cells showed a decrease in adherence of EPEC to Caco2 cells in which CD98 expression was knocked down. In vitro surface plasmon resonance (SPR) experiments showed direct binding between recombinant hCD98 and EPEC/ C. rodentium proteins. We also demonstrated that the partial extracellular loop of hCD98 was sufficient for direct binding to EPEC/ C. rodentium . These findings demonstrate the importance of the extracellular loop of CD98 in the innate host defense response to intestinal infection by attaching and effacing (A/E) pathogens.
- Open Access
- 1 June 2012
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 302 (11) , G1282-G1291
Intestinal epithelial CD98 synthesis specifically modulates expression of colonic microRNAs during colitis
The transmembrane glycoprotein CD98 is known to be involved in intestinal inflammation. In the present study, we found that CD98 overexpression in intestinal epithelial cells does not normally affect the expression of colonic (epithelial and immune cell) microRNAs (miRNAs), small noncoding RNAs that posttranscriptionally regulate a wide variety of biological processes. However, upon dextran sulfate sodium (DSS) treatment, the expression of several colonic miRNAs, but not miRNAs from other tissues such as liver and spleen, were differentially regulated in mice overexpressing CD98 in epithelial cells compared with wild-type (WT) animals. For example, the level of colonic miRNA 132 was not affected by DSS treatment in WT animals but was upregulated in mice overexpressing CD98 in intestinal epithelial cells. Other colonic miRNAs, including colonic miRNA 23a and 23b, were downregulated in WT animals after DSS treatment but not in colonic epithelial cell CD98-overexpressing mice. Interestingly, the expression of potential miRNA target genes affected intestinal epithelial cells that overexpress CD98 and cell types that did not overexpress CD98 but were in close proximity to CD98-overexpressing intestinal epithelial cells. Taken together, these observations show that the combination of an inflammatory context and intestinal epithelial cell expression of CD98 affects the regulation of miRNA expression in colonic epithelial and immune cells. This is new evidence that protein expression modulates miRNA expression and suggests the existence of regulatory crosstalk between proteins and miRNAs in diseases such as colitis.
- 1 June 2012
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 302 (11) , G1282-G1291
Open AccessIntestinal epithelial CD98 synthesis specifically modulates expression of colonic microRNAs during colitis
The transmembrane glycoprotein CD98 is known to be involved in intestinal inflammation. In the present study, we found that CD98 overexpression in intestinal epithelial cells does not normally affect the expression of colonic (epithelial and immune cell) microRNAs (miRNAs), small noncoding RNAs that posttranscriptionally regulate a wide variety of biological processes. However, upon dextran sulfate sodium (DSS) treatment, the expression of several colonic miRNAs, but not miRNAs from other tissues such as liver and spleen, were differentially regulated in mice overexpressing CD98 in epithelial cells compared with wild-type (WT) animals. For example, the level of colonic miRNA 132 was not affected by DSS treatment in WT animals but was upregulated in mice overexpressing CD98 in intestinal epithelial cells. Other colonic miRNAs, including colonic miRNA 23a and 23b, were downregulated in WT animals after DSS treatment but not in colonic epithelial cell CD98-overexpressing mice. Interestingly, the expression of potential miRNA target genes affected intestinal epithelial cells that overexpress CD98 and cell types that did not overexpress CD98 but were in close proximity to CD98-overexpressing intestinal epithelial cells. Taken together, these observations show that the combination of an inflammatory context and intestinal epithelial cell expression of CD98 affects the regulation of miRNA expression in colonic epithelial and immune cells. This is new evidence that protein expression modulates miRNA expression and suggests the existence of regulatory crosstalk between proteins and miRNAs in diseases such as colitis.
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Tu1845 Intestinal Epithelial CD98 Plays a Role in the Host Defense Response to Intestinal Inflammation
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Tu1845 Intestinal Epithelial CD98 Plays a Role in the Host Defense Response to Intestinal Inflammation
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Sa1850 Designing Targeted F4/80-Coated TNFA SiRNA-Loaded Nanoparticles: A Novel Therapeutic Approach to Treat IBD
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Sa1850 Designing Targeted F4/80-Coated TNFA SiRNA-Loaded Nanoparticles: A Novel Therapeutic Approach to Treat IBD
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo2041 A2BAR Exacerbates Intestinal Inflammation
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo2041 A2BAR Exacerbates Intestinal Inflammation
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo1594 The Role Played by PepT1 in Colitis-Associated Cancer
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo1594 The Role Played by PepT1 in Colitis-Associated Cancer
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo2016 Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes With Medium-Chain-Length Fatty Acids in the Colon
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Mo2016 Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes With Medium-Chain-Length Fatty Acids in the Colon
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Overexpression of PepT1 Increases the Susceptibility of Mice to Colitis in a Process Involving NOD2 Activity
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Overexpression of PepT1 Increases the Susceptibility of Mice to Colitis in a Process Involving NOD2 Activity
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Tri-Dap Interacts Directly With the Lrr Domain of NOD1 and Consequently Regulates Rick/NOD1 Interactions
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Tri-Dap Interacts Directly With the Lrr Domain of NOD1 and Consequently Regulates Rick/NOD1 Interactions